CRDF Cardiff Oncology Inc

USD 5.34 -0.41 -7.130435
Icon

Cardiff Oncology Inc (CRDF) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 5.34

-0.41 (-7.13)%

USD 0.18B

0.86M

USD 7.00(+31.09%)

USD 3.50 (-34.46%)

Icon

CRDF

Cardiff Oncology Inc (USD)
COMMON STOCK | NSD
USD 5.34
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.18B

USD 3.50 (-34.46%)

USD 5.34

Cardiff Oncology Inc (CRDF) Stock Forecast

Show ratings and price targets of :
USD 7.00
(+31.09%)

Based on the Cardiff Oncology Inc stock forecast from 1 analysts, the average analyst target price for Cardiff Oncology Inc is USD 7.00 over the next 12 months. Cardiff Oncology Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Cardiff Oncology Inc is Very Bearish, which is based on 0 positive signals and 8 negative signals. At the last closing, Cardiff Oncology Inc’s stock price was USD 5.34. Cardiff Oncology Inc’s stock price has changed by +3.89% over the past week, +193.41% over the past month and +251.32% over the last year.

No recent analyst target price found for Cardiff Oncology Inc
No recent average analyst rating found for Cardiff Oncology Inc

Company Overview Cardiff Oncology Inc

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor to treatment a range of solid tumor cancers and hematologic mali...Read More

11055 Flintkote Avenue, San Diego, CA, United States, 92121

0

December

USD

USA

Adjusted Closing Price for Cardiff Oncology Inc (CRDF)

Loading...

Unadjusted Closing Price for Cardiff Oncology Inc (CRDF)

Loading...

Share Trading Volume for Cardiff Oncology Inc Shares

Loading...

Compare Performance of Cardiff Oncology Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CRDF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Cardiff Oncology Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +0.69 (+0.17%) USD107.38B 29.93 21.06

ETFs Containing CRDF

Symbol Name CRDF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Cardiff Oncology Inc (CRDF) Stock

Based on ratings from 1 analysts Cardiff Oncology Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 1 buy, sell and hold ratings.

Unfortunately we do not have enough data on CRDF's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for CRDF is USD 7.00 over the next 12 months. The maximum analyst target price is USD 7 while the minimum anlayst target price is USD 7.

CRDF stock's Price/Earning ratio is -99,999.99. Our analysis grades CRDF stock's Price / Earning ratio at A. This means that CRDF stock's Price/Earning ratio is above 4.000000000000004% of the stocks in the Biotechnology sector in the NSD exchange. Based on this CRDF may be undervalued for its sector.

The last closing price of CRDF's stock was USD 5.34.

The most recent market capitalization for CRDF is USD 0.18B.

Based on targets from 1 analysts, the average taret price for CRDF is projected at USD 7.00 over the next 12 months. This means that CRDF's stock price may go up by +31.09% over the next 12 months.

We can't find any ETFs which contains Cardiff Oncology Inc's stock.

As per our most recent records Cardiff Oncology Inc has 0 Employees.

Cardiff Oncology Inc's registered address is 11055 Flintkote Avenue, San Diego, CA, United States, 92121. You can get more information about it from Cardiff Oncology Inc's website at https://www.cardiffoncology.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...